APAC Active Pharmaceutical Ingredients (API) Market 2021-2028 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity

1.1 Industry Definition and Research Scope 9

1.1.1 Industry Definition 9

1.1.2 Research Scope 10

1.2 Research Methodology 13

1.2.1 Overview of Market Research Methodology 13

1.2.2 Market Assumption 14

1.2.3 Secondary Data 14

1.2.4 Primary Data 14

1.2.5 Data Filtration and Model Design 15

1.2.6 Market Size/Share Estimation 16

1.2.7 Research Limitations 17

1.3 Executive Summary 18

2 Market Overview and Dynamics 21

2.1 Market Size and Forecast 21

2.1.1 Impact of COVID-19 on World Economy 22

2.1.2 Impact of COVID-19 on the Market 24

2.2 Major Growth Drivers 31

2.3 Market Restraints and Challenges 39

2.4 Emerging Opportunities and Market Trends 42

2.5 Porter’s Fiver Forces Analysis 46

3 Segmentation of Asia Pacific Market by Synthesis 50

3.1 Market Overview by Synthesis 50

3.2 Synthetic API 52

3.2.1 Branded Synthetic API 53

3.2.2 Generic Synthetic API 54

3.3 Biotech API 55

3.3.1 Biotech API by Drug Type 56

3.3.1.1 Monoclonal Antibodies 57

3.3.1.2 Recombinant Proteins 58

3.3.1.3 Vaccines 59

3.3.1.4 Other Biotech APIs 60

3.3.2 Biotech API by Category 61

3.3.2.1 Innovative Biologic API 62

3.3.2.2 Generic Biosimilar API 63

3.3.3 Biotech API by Expression Technology 64

3.3.3.1 Mammalian Expression 65

3.3.3.2 Microbial Expression 66

3.3.3.3 Yeast Expression 67

3.3.3.4 Insect Expression 68

3.3.3.5 Other Expression Technologies 69

3.4 HPAPI 70

3.4.1 Branded HPAPI 71

3.4.2 Generic HPAPI 72

4 Segmentation of Asia Pacific Market by Manufacturing Process 73

4.1 Market Overview by Manufacturing Process 73

4.2 Captive Manufacturing 75

4.2.1 Branded Captive API 76

4.2.2 Generic Captive API 77

4.3 Merchant Manufacturing 78

4.3.1 Merchant Manufacturing by Drug Type 79

4.3.1.1 Branded Merchant API 80

4.3.1.2 Generic Merchant API 81

4.3.2 Merchant Manufacturing by Drug Synthesis 82

4.3.2.1 Merchant Synthetic API 83

4.3.2.2 Merchant Biotech API 84

5 Segmentation of Asia Pacific Market by Therapeutic Application 85

5.1 Market Overview by Therapeutic Application 85

5.2 Infectious Diseases 87

5.3 Oncology 88

5.4 Ophthalmology 89

5.5 Cardiovascular Disorders 90

5.6 Central Nervous System 91

5.7 Pulmonary Disorders 92

5.8 Orthopedics 93

5.9 Other Applications 94

6 Segmentation of Asia Pacific Market by Drug Type 95

6.1 Market Overview by Drug Type 95

6.2 Branded Prescription Drugs 97

6.3 Generic Prescription Drugs 98

6.4 OTC Drugs 99

7 Asia-Pacific Market 2021-2028 by Country 100

7.1 Overview of Asia-Pacific Market 100

7.2 China 103

7.3 Japan 105

7.4 India 108

7.5 Australia 110

7.6 South Korea 112

7.7 Rest of APAC Region 114

8 Competitive Landscape 116

8.1 Overview of Key Vendors 116

8.2 New Product Launch, Partnership, Investment, and M&A 119

8.3 Company Profiles 120

AbbVie Inc. 120

Astrazeneca 122

Aurobindo Pharma Ltd. 127

BASF 130

Bayer AG 133

Boehringer Ingelheim 137

Catalent Inc. 142

Dr. Reddy's Laboratories 145

F. Hoffmann-La Roche 147

GlaxoSmithKline plc 149

Lonza Group 154

Lupin Limited 159

Merck & Co., Inc. 162

Mylan NV 165

Novartis International AG 168

Pfizer Inc. 171

Sanofi 176

Sun Pharmaceutical Industries Ltd. 179

Teva Pharmaceutical Industries Ltd. 182

Thermo Fisher Scientific 184

9 Investing in Asia Pacific Market: Risk Assessment and Management 186

9.1 Risk Evaluation of Asia Pacific Market 186

9.2 Critical Success Factors (CSFs) 189

Related Reports and Products 192

Table 1. Snapshot of Asia Pacific Active Pharmaceutical Ingredients (API) Market in Balanced Perspective, 2021-2028 19

Table 2. World Economic Outlook, 2021-2031 23

Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn 38

Table 4. Main Product Trends and Market Opportunities in Asia Pacific Active Pharmaceutical Ingredients (API) Market 42

Table 5. Asia Pacific Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn 50

Table 6. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Synthetic API by Drug Type, 2018-2028, $ bn 52

Table 7. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Biotech API by Drug Type, 2018-2028, $ bn 56

Table 8. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Biotech API by Category, 2018-2028, $ bn 61

Table 9. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Biotech API by Expression Technology, 2018-2028, $ bn 64

Table 10. Asia Pacific Active Pharmaceutical Ingredients (API) Market: HPAPI by Drug Type, 2018-2028, $ bn 70

Table 11. Asia Pacific Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn 73

Table 12. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Captive Manufacturing by Drug Type, 2018-2028, $ bn 75

Table 13. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Type, 2018-2028, $ bn 79

Table 14. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Synthesis, 2018-2028, $ bn 82

Table 15. Asia Pacific Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn 85

Table 16. Asia Pacific Active Pharmaceutical Ingredients (API) Market by Drug Type, 2018-2028, $ bn 95

Table 17. APAC Active Pharmaceutical Ingredients (API) Market by Country, 2018-2028, $ bn 101

Table 18. China Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn 104

Table 19. China Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn 104

Table 20. China Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn 104

Table 21. Japan Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn 107

Table 22. Japan Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn 107

Table 23. Japan Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn 107

Table 24. India Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn 109

Table 25. India Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn 109

Table 26. India Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn 109

Table 27. Australia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn 111

Table 28. Australia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn 111

Table 29. Australia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn 111

Table 30. South Korea Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn 113

Table 31. South Korea Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn 113

Table 32. South Korea Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn 113

Table 33. Active Pharmaceutical Ingredients (API) Market in Rest of APAC by Country, 2018-2028, $ bn 115

Table 34. AbbVie Inc.: Company Snapshot 120

Table 35. AbbVie Inc.: Product Portfolio 120

Table 36. AbbVie Inc.: Revenue, 2018-2020, $ bn 121

Table 37. Astrazeneca: Company Snapshot 122

Table 38. Astrazeneca: Revenue, 2018-2020, $ bn 123

Table 39. Aurobindo Pharma Ltd.: Company Snapshot 127

Table 40. Aurobindo Pharma Ltd.: Product Portfolio 128

Table 41. BASF: Company Snapshot 130

Table 42. BASF: Business Segmentation 131

Table 43. BASF: Revenue by Region 131

Table 44. Bayer AG: Company Snapshot 133

Table 45. Bayer AG: Business Segmentation 134

Table 46. Bayer AG: Revenue, 2018-2020, € bn 134

Table 47. Boehringer Ingelheim: Company Snapshot 137

Table 48. Boehringer Ingelheim: Business Segmentation in 2019 138

Table 49. Boehringer Ingelheim: Product Portfolio 138

Table 50. Boehringer Ingelheim: Revenue, 2018-2020, EUR billion 139

Table 51. Boehringer Ingelheim: Revenue by Region in 2019 139

Table 52. Catalent Inc.: Company Snapshot 142

Table 53. Catalent Inc.: Business Segmentation in 2018 143

Table 54. Catalent Inc.: Product Portfolio 143

Table 55. Catalent Inc.: Revenue, 2018-2020, $ million 144

Table 56. Catalent Inc.: Revenue by Region in 2018 144

Table 57. Dr. Reddy's Laboratories: Company Snapshot 145

Table 58. Dr. Reddy's Laboratories: Business Segmentation 145

Table 59. Dr. Reddy's Laboratories: Revenue, 2019-2021, $ bn 146

Table 60. F. Hoffmann-La Roche: Company Snapshot 147

Table 61. F. Hoffmann-La Roche: Business Segmentation 148

Table 62. GlaxoSmithKline: Company Snapshot 149

Table 63. GlaxoSmithKline: Business Segmentation 150

Table 64. GlaxoSmithKline: Product Portfolio 151

Table 65. GlaxoSmithKline: Revenue, 2018-2020, $ bn 152

Table 66. Lonza Group: Company Snapshot 154

Table 67. Lonza Group: Business Segmentation in 2018 155

Table 68. Lonza Group: Product Portfolio 155

Table 69. Lonza Group: Revenue by Region in 2018 156

Table 70. Lupin Limited: Company Snapshot 159

Table 71. Lupin Limited: Business Segmentation 159

Table 72. Merck & Co., Inc.: Company Snapshot 162

Table 73. Merck & Co., Inc.: Business Segmentation 162

Table 74. Merck & Co., Inc.: Revenue, 2018-2020, $ bn 163

Table 75. Mylan NV: Company Snapshot 165

Table 76. Mylan NV: Revenue, 2017-2019, $ bn 166

Table 77. Novartis International AG: Company Snapshot 168

Table 78. Novartis International AG: Business Segmentation 168

Table 79. Novartis International AG: Revenue, 2017-2019, $ bn 169

Table 80. Pfizer Inc.: Company Snapshot 171

Table 81. Pfizer Inc.: Business Segmentation 172

Table 82. Pfizer Inc.: Product Portfolio 173

Table 83. Pfizer Inc.: Revenue, 2018-2020, $ bn 173

Table 84. Sanofi: Company Snapshot 176

Table 85. Sanofi: Business Segmentation 176

Table 86. Sanofi: Revenue, 2018-2020, $ bn 177

Table 87. Sun Pharmaceutical Industries Limited: Company Snapshot 179

Table 88. Teva Pharmaceutical Industries Ltd.: Company Snapshot 182

Table 89. Teva Pharmaceutical Industries Ltd.: Business Segmentation 183

Table 90. Thermo Fisher Scientific: Company Snapshot 184

Table 91. Risk Evaluation for Investing in Asia Pacific Market, 2021-2028 187

Table 92. Critical Success Factors and Key Takeaways 190